Dexedrine Capsule, Extended Release
Product Images NDC 64896-675

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dexedrine (NDC 64896-675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexedrine (Chemical Structure)

Dexedrine (Chemical Structure)
Chemical structure of dextroamphetamine sulfate shown as two molecules with a benzene ring attached to a side chain containing an amine group, alongside a sulfate group (H2SO4).*
FDA Label Image

Symbol For Schedule Two Controlled Drug Substance (Dexedrine Dextroamphetamine Sulfate Spansule Susta 2)

Symbol For Schedule Two Controlled Drug Substance (Dexedrine Dextroamphetamine Sulfate Spansule Susta 2)
Label for DEXEDRINE SPANSULE 5 mg extended-release capsules containing dextroamphetamine sulfate, supplied in a bottle of 90 capsules. The label states the National Drug Code (NDC 64896-673-10) and identifies Amneal Pharmaceuticals LLC as the labeler. Storage instructions specify controlled room temperature between 20° and 25°C (68° to 77°F).*
FDA Label Image

5 mg (Container Label)

5 mg (Container Label)
Packaging label for DEXEDRINE SPANSULE 5 mg extended-release capsules containing dextroamphetamine sulfate. The carton indicates 90 capsules per container with federal law dispensing requirements and storage instructions. Labeler is Amneal Pharmaceuticals LLC, distributed by Amneal Specialty, manufactured by Catalent Pharma Solutions.*
FDA Label Image

5 mg (Carton)

5 mg (Carton)
Label for DEXEDRINE SPANSULE 10 mg extended-release capsules, containing dextroamphetamine sulfate. The label states 90 capsules per container, with directions for controlled room temperature storage. It includes the NDC 64896-674-10 and notes manufacturing by Catalent Pharma Solutions and distribution by Amneal Pharmaceuticals LLC.*
FDA Label Image

10 mg (Container Label)

10 mg (Container Label)
Packaging label for DEXEDRINE SPANSULE 10 mg extended-release capsules containing dextroamphetamine sulfate. The label shows the product name, dosage strength, form, quantity of 90 capsules, and manufacturer Amneal Pharmaceuticals LLC, including manufacturing by Catalent Pharma Solutions. It includes federal dispensing law and storage instructions.*
FDA Label Image

10 mg (Carton)

10 mg (Carton)
Label for DEXEDRINE SPANSULE sustained-release capsules containing 15 mg dextroamphetamine sulfate. The label states it is an oral extended-release capsule product with 90 capsules per bottle. It includes storage instructions, manufacturer (Catalent Pharma Solutions), distributor (Amneal Pharmaceuticals LLC), and a federal law warning about dispensing with the Medication Guide. The label also shows the NDC number 64896-675-10 and features the Amneal logo.*
FDA Label Image

15 mg (Container Label)

15 mg (Container Label)
Label for DEXEDRINE SPANSULE 15 mg extended-release capsules, containing dextroamphetamine sulfate. The label shows the 90-capsule count and indicates the product is manufactured by Catalent Pharma Solutions and distributed by Amneal Pharmaceuticals LLC. It includes storage instructions and a federal law dispensing notice. The NDC is 64896-675-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.